Data / Form D filings / Rivus Pharmaceuticals, Inc.
Rivus Pharmaceuticals, Inc.: Form D filings
Rivus Pharmaceuticals, Inc., a pharmaceuticals company in Charlottesville, VA, filed 4 Form D notices with the SEC between 2021 and 2025. The latest, on January 16, 2025, reports $57 million sold of a $57 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 501 LOCUST AVENUE, SUITE 301, Charlottesville, VA, 22902
- Phone
- (703) 456-8000
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1773293
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 16, 2025 | New notice | $56,979,133 | $56,979,133 | 7 | Jan 7, 2025 | sec.gov | |
| Sep 17, 2024 | New notice | $66,000,000 | $66,000,000 | 7 | Aug 9, 2024 | sec.gov | |
| Sep 17, 2024 | New notice | $65,999,999 | $65,999,999 | 7 | Aug 19, 2022 | sec.gov | |
| Oct 4, 2021 | New notice | $35,000,532 | $34,500,000 | $500,532 | 4 | Mar 26, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Schott | Executive Officer | |
| Shaharyar Khan | Executive Officer, Director | |
| Rick Winningham | Director | |
| Allen Cunningham | Executive Officer, Director | |
| Jayson Dallas | Executive Officer, Director | |
| Tom O'Neil | Executive Officer | |
| Derek DiRocco | Director | |
| Ian Smith | Director | |
| Erin Lavelle | Director | |
| Francesco De Rubertis | Director |
Other pharmaceuticals companies in Virginia that filed recently
- Quoin Pharmaceuticals Ltd. $50 million · Sep 10, 2026
Every Form D from the week of Jan 13, 2025 · All recent filings in Virginia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Rivus Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.